03_Pipeline.
03_Pipeline.
Trogenix Pipeline.
This diverse pipeline leverages the versatility of our SSE technology, allowing us to rapidly adapt our approach to different cancer types. We are developing applications beyond oncology in regenerative medicine.
Starting with Glioblastoma (GBM), our platform technology enables us to address the challenges of various aggressive solid tumours where current treatments fall short.
By targeting the fundamental identity and aggressive behaviours of cancer cells, we’re developing a pipeline of precision therapies that could transform treatment paradigms.
The modular nature of our SSE technology creates opportunities not only in oncology but also in regenerative medicine, where we can target the hyper-activated fibroblasts that cause fibrosis and stimulate regeneration and repair.
We Are Revolutionising Cancer Treatment Through Innovative Synthetic Super-Enhancers Technology.
02_Science.